Mitsubishi Chemical Group (MCG) has reported 4.3% increase in its sales revenue to ¥2,242.1 billion in April – September 2024 as compared to ¥2,149.8 billion during April – September 2023.

On the profit front, core operating income rose ¥52.8 billion, or 44.2%, to ¥172.4 billion. Operating income was down ¥1.9 billion, or 1.4%, to ¥136.7 billion. Income before taxes decreased ¥24.1 billion, or 18.5%, to ¥106.1 billion. Meanwhile, net income attributable to owners of the parent dropped ¥26.3 billion, or 39.1% to ¥40.9 billion.

This shows that MCG generally maintained a moderate recovery path, despite some different levels of strength among regions and industries. On the other hand, outlook remained uncertain due to concerns about fluctuations in financial and capital markets caused by policies in various countries, the protracted real estate slump in China, and the expansion of geopolitical risks.

Total assets at the end of the interim consolidated accounting period totaled ¥5,945.2 billion, a decrease of ¥159.3 billion compared with the end of the previous fiscal year. The decrease in total assets was primarily attributable to a decline in the value of assets translated into yen at overseas consolidated subsidiaries mainly from the impact of the appreciation of the yen.